M-Pharma Program Outcomes
1. Advanced Pharmaceutical Formulation Techniques:
Understanding complex drug delivery systems like nanoparticles, liposomes, and microparticles. Developing dosage forms designed to achieve specific drug release profiles.
2. Pharmacokinetic Modeling and Analysis:
Design and analyze pharmacokinetic models for drug absorption, distribution, metabolism and excretion. Adjust drug dosing schedules for maximum therapeutic effect while minimizing side effects.
3. Clinical Trial Design and Management:
Knowledgeable about the clinical trial phases, study protocols, and applicable regulatory requirements. Conducting clinical trials within GCP guidelines in an ethical and effective manner.
4. Pharmaceutical Regulatory Affairs:
Knowledge of international regulations and guidelines as they relate to the drug development, registration, and marketing authorization processes. Regulatory submission preparation and communication with agencies responsible for product approval as defined in the submissions.
5. Pharmacovigilance and Drug Safety:
Monitoring, evaluating, and managing the safety of adverse drug reactions and medication errors during the product life cycle. Developing systems for pharmacovigilance in the area of patient safety and compliance with applicable laws and regulatory requirements.
6. Biopharmaceutical Production and Quality Assurance:
Knowledge of the manufacturing processes of biopharmaceuticals, including bioreactors and purification technologies. Implementation of quality assurance measures relative to product quality, purity, and consistency.
7. Marketing of Pharmaceuticals and Their Market Access
Understanding a company's marketing techniques for pharmaceuticals along with their market evaluation, and product placement, is critical. Consideration of legal, economic, and healthcare system factors for developing market access strategies shows strategic thinking.
8. Drug Discovery and Development
Strong capabilities in molecular modeling, virtual screening, and in silico drug design are essential. Comprehension of drug development processes from target selection to preclinical studies is also necessary.
9. Pharmaceutical Economics and Health Policy
Awareness of the fundamentals of healthcare’s economics, especially concerning pharmaceuticals, pricing, as well as methods of reimbursement is significant. Grasping national policies pertinent to the circulation and cost of medicines, framed within overarching health policies, also matters.
10. Interdisciplinary Collaboration and Communication
Collaboration with pharmacists, doctors, scientists, and policy makers requires diverse professional skills because they are built on different disciplines. Effective presentation and communication skills of the technical material, collaboration and mobilization of different stakeholders within the pharmaceutical sector, and team building are also required.
